Events And

American Diabetes Association’s (ADA) 84th Scientific Sessions

Jun 23, 2024 at 1:45 PM EDT

Presentation Title: Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, in Subjects with Overweight or Obesity –A 48-Week, Placebo-Controlled, Phase 2 (MOMENTUM) Trial

Speaker: Louis Aronne, M.D., Professor of Metabolic Research and Professor of Clinical Medicine, Weil Cornell Medical School


Supporting Materials


Investor Contact


Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail